Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(1):56-65
Telavancin (TLV) is an investigational lipoglycopeptide with multiple mechanism of action. It exhibits rapid bactericidal activity against gram-positive bacteria, including methicillin-susceptible and -resistant, glycopeptide-intermediate and …